SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 179 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $62 | -46.6% | 35,003 | -5.4% | 0.01% | -50.0% |
| Q4 2022 | $116 | -99.9% | 37,007 | +33.5% | 0.01% | -23.1% |
| Q3 2022 | $136,000 | +3.8% | 27,723 | -12.2% | 0.01% | +8.3% |
| Q2 2022 | $131,000 | -2.2% | 31,592 | +36.8% | 0.01% | +200.0% |
| Q1 2022 | $134,000 | +52.3% | 23,101 | +97.1% | 0.00% | +33.3% |
| Q4 2021 | $88,000 | -12.0% | 11,718 | +6.1% | 0.00% | -25.0% |
| Q3 2021 | $100,000 | -33.8% | 11,046 | -8.1% | 0.00% | -66.7% |
| Q1 2021 | $151,000 | – | 12,015 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |